Research type:
|
Secondary Research (e.g. systematic review) |
Title (lead author) etc:
|
Screening for cystic fibrosis-related diabetes: a systematic review (Waugh) 179 pages, Volume 16, number 24 |
DOI
|
10.3310/hta16240 |
View/print executive summary
View/print abstract
View full text in pdf format (1131 KB)
Go to our correspondence page to comment on this publication
|
Headline: |
Report finds some evidence suggesting that harm to pulmonary function in patients with cystic fibrosis-related diabetes (CFRD) occurs at lower blood glucose levels than those used for defining other types of diabetes, and suggests that the definition of CFRD should be based on pulmonopathy risk, rather than using the classical definition of diabetes. Treatment should perhaps start below the usual thresholds for diagnosing diabetes. |
This report should be referenced as follows: |
Waugh N, Royle P, Craigie I, Ho V, Pandit L, et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol Assess
2012;16(24).
|
Project ref: |
07/45/05 |
Original project title: |
Screening for disorders of glucose regulation in cystic fibrosis |
Chief Investigator: |
Professor Norman Waugh, Professor of Public Health,
Warwick Evidence, University of Warwick
|
Start Date: |
July 2008 |
Date of publication in HTA journal series |
May 2012
|
Cost: |
£93,878 |
Project Protocol: |
Project protocol not available
|
Printed copies of this title despatched:
|
87 (Figures relate to the previous calendar month) |
URL of this page: |
http://www.hta.ac.uk/1706 |
News feeds